Purpose: Transscleral contect-cyclophotocoagulation has been used more end more in the treatment of therapy-refractive glaucomas, in recent years. A less pain sensation, reported by the patients, during b-eatment in comparison with cycle-cryocoagulatio was one important reason for increased usuage. The dose-effect correlation for exposure time, energy used and number of the laser impacts various according to different authors. This retrospective study (tied to d&tine if there is a dw-effect correlation of the tmnssclerai contaet-cyclophotoccegulation.
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Methods: 124 eyes of I13 patients (62 female, 62 male, range of age 49.9 f 26,5 years) were included in this study according to their diagnosis (congerdbd ghwwma. secundary glaucoma, primary opm glaucoma, small angle glaucoma). The used energy, number of laser impacts, exposure time and laserpower were reviewed along with the intm-wular pressurn (IOP) before treatment, after treatment and during the follow-up (mean 6 months). A medication-score was used to register the antiglaucomatous drugs.
Results: 45.2 % (56) of 124 eyes had an IOP of < 22 mm Hg. 25.8 96 (32) were treated up to live times. A clinical correlation between energy and decrease of IOP was not found (p, = 0,0815 non significant, speermann rank-correlation). The IOP was reduced sigoificantly from 35.8 f 10.5 mm Hg pre-op lo 263 f 10.5 mm Hg at the end of follow-up (p = 0, WilcoxanTest). Up to 3 antiglaucomatous drugs could be saved in therapy-refractive eyes to reach an IOP of 21 mm Hg or less.
Conclusions:
This data shows that a decrease about 10 mm Hg of the IOP is possible using Ihe transsclwal fontact-cyclophotocO~oa.
In therapyrefractive eyes. less drugs were needed to reach so IOP < 22 mm Hg. Regardless the diagnosis, a dose-effect correlation between the decrease of IOP aad laser energy was not found. IO, 20 and 50 pm Mesh were selected lor a pilo! study (30 rabbits. over 3 mos folkwbp). A sham study was made on 5 rabbils 10 evaluate the effect of the surQbal P rooBdIJrs WPhoui implamation of Mesh. .SurQely was pwformd on the rfQht eye, the en we served as a control for IOP and outflow measurements. w : The flow was function of the materiars shuoture, lhiiness and density. The 60 and 2U urn had a mbmlihriilar slruclure. whereas the 10 um had a dense strwlure krHh pores distributed randomly abnQ the surface. In the iham group, (he IOP and outflow returned to normal at POD 14. In the Inplanted group, surgery took 5.7 minutes. The implant, tie at the beginning, became wansboem afbr 5 to 10 days and was found biocanlpatible. In all cases the IOP was reduced and the outflow increased in the implanted eye during all Ihe time of the follow-up. The 50 w was biocobnized in 21 days, few cells were presenl at 3 month in the 20 urn and no colonization was ohsewed in the 10 pm. The lafl of all implants was encapsulated al 3 month buf the head remained free of encapsulatbn. &Q&@JM : This pilot study revealed that fhe Mesh and the implanlatbn concepts are Well tolerated, less invasive and require less wrpical time than most other QlauComa sur~bal procedures. We demonstrated the effbbnoy ol the Mesh in reduoinQ the IOP and ib safely for the eye. (16 patients, 57.1%) . hypertony (7 patients, 25%), serous choroidal effusion (7 patients. 25%). fibrinous uveitis (5 patients, 17.9%), blockage of the intracameral portion of the tuba by fibrin (5 patients, 17.9%). chomidal hemOtTheQe (2 patients, 7.1%). Late complications were: external conjunclival bleb failure (12 patients. 42.9%). blOcl(pQe of the intracameral portion of the tube by fibrovascular tissue (5 patients. 17.9%), cataract (2 patients. 7.1%). bulbus karatopathy (2 patients. 7.1%). external amsion of the SilaStiC valve (2 patients, 7.1%). phthisia bulbi (2 patients. 7.1%).
Mortality
during long-term follow-up 'was hiQh in' a& series. The complications of an underlvina diabetes mellitus were the most common c&es of death (15 out 
